Insulin can alter myocardial contractility, in part through an effect on the cardiac sarcolemmal Na ؉ /Ca 2؉ exchanger (NCX), but little is known about its mechanism of action. The large cytoplasmic domain (f-loop) of NCX is required for regulation by various intracellular factors, and we have shown previously that residues 562-679 are determinants of NCX inhibition by exchanger inhibitory peptide (XIP). Here we show that the same f-loop deletion eliminates the enhancement of NCX current by insulin, and we examine the signal pathways involved in the insulin response. NCX current (I NCX ) was measured in freshly isolated or cultured (up to 48 h) adult guinea pig myocytes and in myocytes expressing canine NCX1.1 with the 562-679 f-loop deletion (NCX-(⌬562-679)) via adenoviral gene transfer. I NCX was recorded by whole-cell patch clamp as the Ni 2؉ -sensitive current at 37°C with intracellular Ca 2؉ buffered. Insulin (1 M) increased I NCX (at ؉80 mV) by 110 and 83% in fresh and cultured myocytes, respectively, whereas in myocytes expressing NCX-(⌬562-679) the response was eliminated (with 100 M XIP included to suppress any native guinea pig I NCX ). The insulin effect on I NCX was not inhibited by wortmannin, a nitricoxide synthase inhibitor, or disruption of caveolae but was blocked by chelerythrine, implicating protein kinase C, but not phosphatidylinositol-3-kinase, in the mechanism. The insulin effect was also not additive with phosphatidylinositol-4,5-bisphosphate-induced activation of I NCX . The finding that the 562-670 f-loop domain is implicated in both XIP and receptormediated modulation of NCX highlights its important role in acute physiological or pathophysiological regulation of Ca 2؉ balance in the heart.Insulin is an essential hormone for the control of blood glucose concentration. In the heart, insulin affects many physiological and pathological functions, including energy metabolism, contractility (1, 2), ion transport (3), cardiac protection (4), hypertrophy (5), and cardiomyopathy in diabetes (6). The sarcolemmal Na ϩ /Ca 2ϩ exchanger (NCX) 2 has been shown to be an insulin-sensitive target; NCX protein and mRNA expression levels are significantly depressed in some diabetic animal models (7,8), and NCX activity, but not mRNA, was decreased in streptozotocin-treated neonatal rats (9). NCX regulation by insulin has also been proposed as one of the underlying mechanisms responsible for the positive inotropic effect of insulin on the failing myocardium (10, 11). Because NCX is the main mechanism for removing Ca 2ϩ from the cell, accounting for up to 30% of the total systolic Ca 2ϩ removal in large animals, a significant reduction in exchanger activity could increase intracellular Ca 2ϩ and may contribute to diabetic cardiomyopathy as a result of altered diastolic Ca 2ϩ removal (12). The pleiotropic actions of insulin are mediated by a cascade of parallel signaling pathways within the cell. The binding of insulin to its receptor results in the activation of its intrinsic protein tyrosine kinase activi...